Loading clinical trials...
Loading clinical trials...
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Evommune, Inc.
NCT07358364 · Chronic Spontaneous Urticaria
NCT06931405 · Chronic Inducible Urticaria, Chronic Spontaneous Urticaria
NCT07230418 · Chronic Spontaneous Urticaria
NCT07219615 · Chronic Spontaneous Urticaria
NCT07021495 · Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), and more
Cahaba Dermatology Skin Health Center
Birmingham, Alabama
Velocity Clinical Research, Mobile
Mobile, Alabama
Center for Dermatology Clinical Research
Fremont, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions